Pharmaceutical Companies

Subscribe to industry newsletters

Share us

Advertise with us
Advertise & RatesMy Account
Company press officeList company
Recruitment packagesSubmit job ad
Download ratecard
Adcock Ingram bleeding money
Adcock Ingram bleeding money

Drug maker Adcock Ingram reported a headline loss per share of 179.5c for the nine months to June from headline earnings of 271.7c in the prior period.

29 Aug 2014 06:27

Registering drugs once could halve cost of medication
Registering drugs once could halve cost of medication

The International Generic Drug Regulators Pilot (IGDRP) is promoting the movement to permit pharmaceutical companies to register a product only once in the country of their choice, in order to market it elsewhere in the world.

21 Aug 2014 16:09

Ascendis Health acquires six products from Arctic Healthcare
Ascendis Health acquires six products from Arctic Healthcare

Ascendis Health has acquired six leading products from Arctic Healthcare, in a deal valued at R151 million. These are Chela-Fer, Menacal7, Chela-Preg, Chela-Mag, Osteoflex and Supa Chewz.

12 Aug 2014 14:48

Pfizer, NWU sign MOU for potential collaboration on pre-clinical R&D
Pfizer, NWU sign MOU for potential collaboration on pre-clinical R&D

Pfizer and North-West University have signed a MOU outlining the basis for potential scientific and technical collaborations.

3 Jul 2014 12:13

New exco for National Association of Pharmaceutical Manufacturers
New exco for National Association of Pharmaceutical Manufacturers

The National Association of Pharmaceutical Manufacturers has announced its new exco. Taking over the reigns as the association's chairperson is Desmond Brothers, CEO of Ranbaxy, who will be assisted by the new vice-chairperson, Herman Grobler, COO of Cipla.

1 Jul 2014 11:23

Ascendis Health, MIC in R200-million empowerment deal
Ascendis Health, MIC in R200-million empowerment deal

Ascendis Health announced last week that it has concluded an agreement with the Mineworkers Investment Company (MIC), which will see the BEE ownership in Ascendis increase over a three-year period.

1 Jul 2014 11:18

JSE investigates Aspen trading activity last week
JSE investigates Aspen trading activity last week

The JSE said it is investigating trading activity in pharmaceutical stock Aspen, which took place ahead of last week's investor conference call and led to a major dip in the share price.

By Evan Pickworth 1 Jul 2014 10:15

Aspen says management comments taken "out of context"
Aspen says management comments taken "out of context"

Aspen Pharmacare is attempting to eliminate uncertainty regarding its second-half earnings by saying certain comments made by its management team at a conference call last week were misconstrued and taken out of context.

1 Jul 2014 06:36

MMI buys CareCross group
MMI buys CareCross group

Insurer MMI Holdings has bought the CareCross Health Group for an undisclosed sum‚ which it says will allow it to reduce healthcare costs.

20 Jun 2014 10:28

Ascendis Health acquires Respiratory Care Africa for R145 million
Ascendis Health acquires Respiratory Care Africa for R145 million

Subject to the regulatory consent of the South African Competition Authorities, Ascendis Health has acquired Respiratory Care Africa, a specialist medical devices company, for R 145 million in a cash and shares deal.

17 Jun 2014 14:53

Glaxo in USD350m cancer deal with biotech specialist
Glaxo in USD350m cancer deal with biotech specialist

LONDON, UK: British pharmaceuticals giant GlaxoSmithKline has agreed to a US$350-million deal with Adaptimmune to help develop and sell the biotechnology firm's cancer drugs, the companies said on Monday, 2 June 2014.

3 Jun 2014 15:37

Adcock shareholders have PIC to thank for loss after CFR buyout

Had the Public Investment Corporation (PIC) not blown the Chilean pharmaceutical company CFR's bid for Adcock Ingram out of the water late last year, Adcock's shareholders would now have a huge return.

By Stuart Theobald 3 Jun 2014 11:03

Adcock Ingram announces decentralisation‚ drop in profit
Adcock Ingram announces decentralisation‚ drop in profit

Pharmaceutical and healthcare products group Adcock Ingram Holdings would be reorganised into a decentralised structure from 1 July‚ Kevin Wakeford‚ the recently appointed Chief Executive of the group said.

By Charlotte Mathews 29 May 2014 12:39

AstraZeneca Pharmaceuticals expands to Zambia

AstraZeneca Pharmaceuticals, operational in 11 sub-Saharan African countries, has announced that it is launching into Zambia, initially focusing on providing cardiovascular, respiratory and gastrointestinal drugs and expanding its product portfolio to cover diseases like oncology and diabetes.

28 May 2014 10:36

Show more
No jobs found